EUVIMEDEUVIMED entdecken
Open Access

In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis

Hongqi Teng iD, Qinglei Hang iD, Caishang Zheng iD, Yuelong Yan iD, Shaomin Liu iD, Yang Zhao iD, Yalan Deng iD, Litong Nie iD, Weiche Wu, Marisela Sheldon, Zachary Yu iD, Wei Shi iD und 10 weitere

Science Translational Medicine · 21.05.2025 · 17 (799)

DOI: 10.1126/scitranslmed.ado7225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 21.05.2025. Verfasst von Hongqi Teng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, Diazepam Binding Inhibitor, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most common sites of cancer metastasis is to the bone. Bone metastasis is associated with substantial morbidity and mortality, and current therapeutic interventions remain largely palliative. Metastasizing tumor cells need to reprogram their metabolic states to adapt to the nutrient environment of distant organs; however, the role and translational relevance of lipid metabolism in bone metastasis remain unclear. Here, we used an in vivo CRISPR activation screening system coupled with positive selection to identify acyl–coenzyme A (CoA) binding protein (ACBP) as a bone metastasis driver. In nonmetastatic and weakly metastatic cancer cells, overexpression of wild-type ACBP, but not the acyl-CoA–binding deficient mutant, stimulated fatty acid oxidation (FAO) and bone metastasis. Conversely, knockout of ACBP in highly bone metastatic cancer cells abrogated metastatic bone colonization. Mechanistically, ACBP-mediated FAO increased ATP and NADPH production, reduced reactive oxygen species, and inhibited lipid peroxidation and ferroptosis. We found that ACBP expression correlated with metabolic signaling, bone metastatic ability, and poor clinical outcomes. In mouse models, pharmacological blockade of FAO or treatment with a ferroptosis inducer inhibited bone metastasis. Together, our findings reveal the role of lipid metabolism in tumor cells adapting and thriving in the bone and identify ACBP as a key regulator of this process. Agents that target FAO or induce ferroptosis represent a promising therapeutic approach for treating bone metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsDiazepam Binding InhibitorClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsAnimalsHumansCell Line, TumorMiceLipid MetabolismFatty AcidsReactive Oxygen SpeciesFerroptosisOxidation-ReductionNeoplasm MetastasisFemale

Substanzen

Diazepam Binding InhibitorFatty AcidsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Chemistry, Rice University, Houston, TX 77005, USA.
  • Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, China.
  • Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200080, China.
  • Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Hongqi Teng, Qinglei Hang, Caishang Zheng, Yuelong Yan, Shaomin Liu, Yang Zhao, Yalan Deng, Litong Nie, Zachary Yu, Wei Shi, Chenling Meng, Jie Zhang, Fan Yao, Yutong Sun, Di Zhao, Boyi Gan, Tong Meng, Li Ma

Förderung

  • NCI NIH HHS

Zitieren

APA

Teng, H., Hang, Q., Zheng, C., Yan, Y., Liu, S., Zhao, Y., Deng, Y., Nie, L., Wu, W., Sheldon, M., Yu, Z., Shi, W., Gao, J., Meng, C., Martinez, C., Zhang, J., Yao, F., Sun, Y., Zhao, D., …, & Ma, L. (2025). In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis. Science Translational Medicine, 17(799). https://doi.org/10.1126/scitranslmed.ado7225

Vancouver

Teng H, Hang Q, Zheng C, Yan Y, Liu S, Zhao Y, et al. In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis. Science Translational Medicine. 2025;17(799). doi:10.1126/scitranslmed.ado7225

BibTeX
@article{Teng2025,
  author = {Teng, Hongqi and Hang, Qinglei and Zheng, Caishang and Yan, Yuelong and Liu, Shaomin and Zhao, Yang and Deng, Yalan and Nie, Litong and Wu, Weiche and Sheldon, Marisela and Yu, Zachary and Shi, Wei and Gao, Jianxuan and Meng, Chenling and Martinez, Consuelo and Zhang, Jie and Yao, Fan and Sun, Yutong and Zhao, Di and Gan, Boyi and Meng, Tong and Ma, Li},
  title = {In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {799},
  doi = {10.1126/scitranslmed.ado7225}
}
Kostenlos starten →